Skip to main content
Erschienen in:

26.11.2018 | Original Scientific Report

Postoperative Skeletal Muscle Loss Predicts Poor Prognosis of Adenocarcinoma of Upper Stomach and Esophagogastric Junction

verfasst von: Kensuke Kudou, Hiroshi Saeki, Yuichiro Nakashima, Koichi Kimura, Koji Ando, Eiji Oki, Tetsuo Ikeda, Yoshihiko Maehara

Erschienen in: World Journal of Surgery | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The relationship between postoperative changes in muscle mass and the prognosis of malignancies remains controversial. We aimed to determine whether a decrease in skeletal muscle mass after surgical resection can predict long-term outcomes in patients with adenocarcinoma of upper stomach (AUS) and esophagogastric junction (AEGJ).

Methods

We reviewed 146 patients who underwent curative surgery for AUS and AEGJ. We assessed the skeletal muscle index pre- and post-surgery and 6 months postoperatively. The rate of decrease in skeletal muscle index (SMI) was calculated and its relationship with clinicopathological factors and prognosis was analyzed.

Results

Among the 146 patients studied, 115 underwent re-assessment of SMI 6 months postoperatively. The mean decrease in SMI was more prominent in patients with recurrence than in those without recurrence (19.0 ± 2.3 vs. 7.4 ± 0.9%, respectively, P < 0.0001). AUS and AEGJ patients with a >19% decrease in SMI showed significantly lower 5-year overall survival and recurrence-free rates than those with a <19% decrease in SMI (recurrence-free survival: 33.4 vs. 89.2%, respectively, P < 0.0001; overall survival: 40.6 vs. 90.0%, respectively, P < 0.0001). Multivariate analyses indicated that a ≥19% decrease in SMI could predict poor overall survival independently in patients with AUS and AEGJ (P = 0.0070).

Conclusions

A ≥19% postoperative decrease in SMI was substantially associated with poor survival in patients with AUS and AEGJ.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Carey S, Storey D, Biankin AV et al (2011) Long term nutritional status and quality of life following major upper gastrointestinal surgery—a cross-sectional study. Clin Nutr 30:774–779CrossRefPubMed Carey S, Storey D, Biankin AV et al (2011) Long term nutritional status and quality of life following major upper gastrointestinal surgery—a cross-sectional study. Clin Nutr 30:774–779CrossRefPubMed
2.
Zurück zum Zitat Harimoto N, Shirabe K, Yamashita YI et al (2013) Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 100:1523–1530CrossRefPubMed Harimoto N, Shirabe K, Yamashita YI et al (2013) Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 100:1523–1530CrossRefPubMed
3.
Zurück zum Zitat Fujiwara N, Nakagawa H, Kudo Y et al (2015) Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63:131–140CrossRefPubMed Fujiwara N, Nakagawa H, Kudo Y et al (2015) Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63:131–140CrossRefPubMed
4.
Zurück zum Zitat Go SI, Park MJ, Song HN et al (2016) Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer. Support Care Cancer 24:2075–2084CrossRefPubMed Go SI, Park MJ, Song HN et al (2016) Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer. Support Care Cancer 24:2075–2084CrossRefPubMed
5.
Zurück zum Zitat Miyamoto Y, Baba Y, Sakamoto Y et al (2015) Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22:2663–2668CrossRefPubMed Miyamoto Y, Baba Y, Sakamoto Y et al (2015) Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22:2663–2668CrossRefPubMed
6.
Zurück zum Zitat Choi Y, Oh DY, Kim TY et al (2015) Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index. PLoS ONE 10:e0139749CrossRefPubMedPubMedCentral Choi Y, Oh DY, Kim TY et al (2015) Skeletal muscle depletion predicts the prognosis of patients with advanced pancreatic cancer undergoing palliative chemotherapy, independent of body mass index. PLoS ONE 10:e0139749CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Dodson S, Baracos VE, Jatoi A et al (2011) Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 62:265–279CrossRefPubMed Dodson S, Baracos VE, Jatoi A et al (2011) Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies. Annu Rev Med 62:265–279CrossRefPubMed
8.
Zurück zum Zitat Tamandl D, Paireder M, Asari R et al (2016) Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 26:1359–1367CrossRefPubMed Tamandl D, Paireder M, Asari R et al (2016) Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 26:1359–1367CrossRefPubMed
9.
Zurück zum Zitat Tegels JJ, van Vugt JL, Reisinger KW et al (2015) Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol 112:403–407CrossRefPubMed Tegels JJ, van Vugt JL, Reisinger KW et al (2015) Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol 112:403–407CrossRefPubMed
10.
11.
Zurück zum Zitat Von Haehling S, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachex Sarcopenia Muscle 1:129–133CrossRef Von Haehling S, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachex Sarcopenia Muscle 1:129–133CrossRef
12.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423CrossRefPubMedPubMedCentral Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bozzetti F, Ravera E, Cozzaglio L et al (1990) Comparison of nutritional status after total or subtotal gastrectomy. Nutrition 6:371–375PubMed Bozzetti F, Ravera E, Cozzaglio L et al (1990) Comparison of nutritional status after total or subtotal gastrectomy. Nutrition 6:371–375PubMed
14.
Zurück zum Zitat Takachi K, Doki Y, Ishikawa O et al (2006) Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res 130:1–7CrossRefPubMed Takachi K, Doki Y, Ishikawa O et al (2006) Postoperative ghrelin levels and delayed recovery from body weight loss after distal or total gastrectomy. J Surg Res 130:1–7CrossRefPubMed
15.
Zurück zum Zitat Kudou K, Saeki H, Nakashima Y et al (2017) Prognostic significance of sarcopenia in patients with Esophagogastric junction cancer or upper gastric cancer. Ann Surg Oncol 24:1804–1810CrossRefPubMed Kudou K, Saeki H, Nakashima Y et al (2017) Prognostic significance of sarcopenia in patients with Esophagogastric junction cancer or upper gastric cancer. Ann Surg Oncol 24:1804–1810CrossRefPubMed
16.
Zurück zum Zitat Kobayashi A, Kaido T, Hamaguchi Y et al (2016) Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 23:57–64CrossRefPubMed Kobayashi A, Kaido T, Hamaguchi Y et al (2016) Impact of postoperative changes in sarcopenic factors on outcomes after hepatectomy for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 23:57–64CrossRefPubMed
17.
Zurück zum Zitat Fukushima H, Nakanishi Y, Kataoka M et al (2017) Postoperative changes in skeletal muscle mass predict survival of patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. Clin Genitourin Cancer 15:e229–e238CrossRefPubMed Fukushima H, Nakanishi Y, Kataoka M et al (2017) Postoperative changes in skeletal muscle mass predict survival of patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy. Clin Genitourin Cancer 15:e229–e238CrossRefPubMed
18.
Zurück zum Zitat Miyake M, Morizawa Y, Hori S et al (2017) Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder. BMC Cancer 17:237CrossRefPubMedPubMedCentral Miyake M, Morizawa Y, Hori S et al (2017) Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder. BMC Cancer 17:237CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Park SY, Yoon JK, Lee SJ et al (2017) Postoperative change of the psoas muscle area as a predictor of survival in surgically treated esophageal cancer patients. J Thorac Dis 9:355–361CrossRefPubMedPubMedCentral Park SY, Yoon JK, Lee SJ et al (2017) Postoperative change of the psoas muscle area as a predictor of survival in surgically treated esophageal cancer patients. J Thorac Dis 9:355–361CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Kinoshita A, Onoda H, Imai N et al (2012) Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107:988–993CrossRefPubMedPubMedCentral Kinoshita A, Onoda H, Imai N et al (2012) Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 107:988–993CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Ignacio de Ulibarri J, Gonzalez-Madrono A et al (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20:38–45PubMed Ignacio de Ulibarri J, Gonzalez-Madrono A et al (2005) CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 20:38–45PubMed
22.
Zurück zum Zitat Yamanaka T, Matsumoto S, Teramukai S et al (2007) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73:215–220CrossRefPubMed Yamanaka T, Matsumoto S, Teramukai S et al (2007) The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 73:215–220CrossRefPubMed
23.
Zurück zum Zitat Wei XL, Wang FH, Zhang DS et al (2015) A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. BMC Cancer 15:350CrossRefPubMedPubMedCentral Wei XL, Wang FH, Zhang DS et al (2015) A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. BMC Cancer 15:350CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Pan QX, Su ZJ, Zhang JH et al (2015) A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. Onco Targets Ther 8:1375–1385CrossRefPubMedPubMedCentral Pan QX, Su ZJ, Zhang JH et al (2015) A comparison of the prognostic value of preoperative inflammation-based scores and TNM stage in patients with gastric cancer. Onco Targets Ther 8:1375–1385CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Siewert JR, Stein HJ (1996) Carcinoma of the cardia: carcinoma of the gastroesophageal junction-classification, pathology and extent of resection. Dis Esophagus 9:173–182CrossRef Siewert JR, Stein HJ (1996) Carcinoma of the cardia: carcinoma of the gastroesophageal junction-classification, pathology and extent of resection. Dis Esophagus 9:173–182CrossRef
27.
Zurück zum Zitat Yoshizumi T, Shirabe K, Nakagawara H et al (2014) Skeletal muscle area correlates with body surface area in healthy adults. Hepatol Res 44:313–318CrossRefPubMed Yoshizumi T, Shirabe K, Nakagawara H et al (2014) Skeletal muscle area correlates with body surface area in healthy adults. Hepatol Res 44:313–318CrossRefPubMed
28.
Zurück zum Zitat Matsubara Y, Matsumoto T, Aoyagi Y et al (2015) Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia. J Vasc Surg 61:945–950CrossRefPubMed Matsubara Y, Matsumoto T, Aoyagi Y et al (2015) Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia. J Vasc Surg 61:945–950CrossRefPubMed
29.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196CrossRefPubMed
31.
Zurück zum Zitat Tegels JJ, van Vugt JL, Reisinger KW et al (2015) Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol 112:403–407CrossRefPubMed Tegels JJ, van Vugt JL, Reisinger KW et al (2015) Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol 112:403–407CrossRefPubMed
32.
Zurück zum Zitat Tamandl D, Paireder M, Asari R et al (2016) Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 26:1359–1367CrossRefPubMed Tamandl D, Paireder M, Asari R et al (2016) Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol 26:1359–1367CrossRefPubMed
33.
Zurück zum Zitat Aoi W, Naito Y, Takagi T et al (2013) A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 62:882–889CrossRefPubMed Aoi W, Naito Y, Takagi T et al (2013) A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 62:882–889CrossRefPubMed
34.
Zurück zum Zitat Hojman P, Dethlefsen C, Brandt C et al (2011) Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth. Am J Physiol Endocrinol Metab 301:E504–E510CrossRefPubMed Hojman P, Dethlefsen C, Brandt C et al (2011) Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth. Am J Physiol Endocrinol Metab 301:E504–E510CrossRefPubMed
Metadaten
Titel
Postoperative Skeletal Muscle Loss Predicts Poor Prognosis of Adenocarcinoma of Upper Stomach and Esophagogastric Junction
verfasst von
Kensuke Kudou
Hiroshi Saeki
Yuichiro Nakashima
Koichi Kimura
Koji Ando
Eiji Oki
Tetsuo Ikeda
Yoshihiko Maehara
Publikationsdatum
26.11.2018
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 4/2019
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-018-4873-6

Neu im Fachgebiet Chirurgie

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Appendizitis und Darminfarkt durch Blinddarm-Lipom

Eigentlich sind Lipome recht harmlos. Im Zäkum können sie jedoch erhebliche Komplikationen mit Darminfarkt und Appendizitis verursachen.

Gluteuslappen nach Rektumkarzinom-Op. schützt vor Abszessen

Die Wunddeckung mit einem autologen Rotationslappen nach Entfernung eines Rektumkarzinoms konnte in einer randomisierten Studie gegenüber dem primären Wundverschluss vor allem in einer Hinsicht punkten: Sie führte deutlich seltener zu präsakralen Abszessen.

MedTalk Leitlinie KOMPAKT: S3-Leitline zu peripheren Nervenverletzungen

  • Webinar | 10.02.2025 | 13:00

Über den Weg zur finalen Fassung der S3-Leitlinie "Versorgung peripherer Nervenverletzungen" sprechen Prof. Dr. Leila Harhaus-Wähner und Ressortleiter Dr. Gunter Freese im WebTalk Leitlinie KOMPAKT, einer neuen Webcast-Serie von SpringerMedizin passend zu Ihrem Fachmagazin Orthopädie und Unfallchirurgie Mitteilungen und Nachrichten. In dem kurzen Video geht es darum, was sich im Vergleich zur vorigen Fassung der Leitlinie geändert hat, welche Aspekte für die tägliche Praxis besonders wichtig sind und was jeder gemäß Leitlinie nun anders oder besser machen sollte.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.